Navigation Links
InBios' Dengue IgM ELISA Continues to Prove Fast and Effective for Presumptive Diagnosis of Dengue Virus Infection
Date:8/27/2013

Seattle, WA (PRWEB) August 27, 2013

A new study conducted by researchers at the John A. Burns School of Medicine, University of Hawaii, evaluated the InBios DENV Detect IgM Capture ELISA for qualitative detection of IgM antibodies to dengue virus recombinant antigens (1). Well characterized clinical serum samples collected from Hawaii, Vietnam, Niue, Singapore and American Samoa were tested with the DENV Detect IgM Capture ELISA in comparison with in-house DENV IgM antibody capture (MAC) ELISA. The agreement, sensitivity, and specificity of the InBios assay were 94, 92 and 94% respectively. The study found that InBios’ DENV Detect IgM Capture ELISA is advantageous compared to the in-house MAC-ELISA, as the results can be obtained in less than 5 hours, whereas the in-house MAC-ELISA requires 2 to 3 days.

The study, titled “Evaluation of a New Commercially Available Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assay for Diagnosis of Dengue Virus Infection,” was published in the Journal of Clinical Microbiology, July 2013;51(9):3102-6.

This study was supported in part by grants P20GM103516, U01AI078213 and U54MD007584 from the National Institutes of Health, grant W81XWH0720073 from the Department of Defense and by institutional funds.

About Dengue:

Dengue is a significant human pathogen of global importance. Today about 2.5 billion people, or 40% of the world’s population, live in areas where there is a risk of dengue transmission. Dengue is endemic in at least 100 countries in Asia, the Pacific, the Americas, Africa and the Caribbean. The World Health Organization (WHO) estimates that 50 to 100 million infections occur yearly, including 500,000 DHF cases and 22,000 deaths, mostly among children (4). Recently there have been reported outbreaks in Kenya (May 2013) and Angola (June 2013) (2). Although most of the reported cases in the Unites States are acquired by travelers or immigrants, autochthonous dengue fever outbreaks have occurred in Brownsville, TX (2005), southern Florida (2009-2011) and Hawaii (2011) (3).

About InBios International, Inc.:

InBios International, Inc., located at 562 1st Ave. South, Suite 600, Seattle, WA, USA, manufactures diagnostic tests for infectious diseases. InBios is an FDA registered facility and ISO 13485:2003 Certified. The company manufactures a full range of dengue products including ELISA kits for Dengue IgM, IgG, and NS1 and a rapid test for Dengue NS1. All products are manufactured in the USA.

References:
(1)    Namekar M, Ellis EM, O’Connell M, Elm J, Gurary A, Park SY, Imrie A and Nerurkar VR. Evaluation of a New Commercially Available Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assay for Diagnosis of Dengue Virus Infection. J Clinical Microbiol. 2013; 51:3102.
(2)    http://www.cdc.gov/dengue/travelOutbreaks/
(3)    Bouri N, Kirk Sell T, Franco C, Adalja AA, Henderon DA and Hynes NA. Return of Epidemic Dengue in the Unites States: Implications for the Public Health Practitioner. Public Health Rep. 2012;127:259.
(4)    http://www.cdc.gov/dengue/epidemiology/

Read the full story at http://www.prweb.com/releases/2013/8/prweb11058705.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New findings could influence the development of therapies to treat dengue disease
2. NTU designs social media and web system that can predict dengue hotspots
3. Mast cells give clues in diagnosis, treatment of dengue
4. Warning system predicts outbreaks of dengue fever
5. La Jolla Institutes surprising finding could alter the face of dengue vaccine development
6. Global burden of dengue is triple current estimates
7. Homegrown Strain of Dengue Fever Virus Pinpointed in Florida
8. Tracking the spread of dengue fever: Domestic networks drive rapid transmission of human infection
9. NIH-developed candidate dengue vaccine shows promise in early-stage trial
10. Experimental Dengue Vaccine Shows Some Success
11. Dengue Vaccine Initiative welcomes latest progress in vaccine development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Research ... "Structural Electronics 2015-2025: Applications, Technologies, Forecasts" ... In-Mold Electronics, Smart Skin, Structural Health ... Structural electronics involves electronic and/or electrical ... structures, replacing dumb structures such as vehicle bodies ...
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: